November 18, 2015
Kit Lam, professor and chair of the Department of Biochemistry and Molecular Medicine, has been awarded two major, multi-disciplinary U01 grants from the National Institutes of Health (NIH), the first to investigate use of a new tool to visualize cancer tumor growth and response to nanoparticle drugs, and the other to develop a new 4-D imaging tool to advance the understanding of how the nucleus functions in living cells.
November 17, 2015
Researchers at the UC Davis Comprehensive Cancer Center have shown that the microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer.
November 4, 2015
Karen Kelly, associate director for clinical research at the UC Davis Comprehensive Cancer Center, has been named chair of the Lung Committee of SWOG, one of the nation’s leading cooperative cancer research organizations.
October 22, 2015
John D. McPherson, a basic scientist whose work contributed significantly to the sequencing of the human genome, has assumed the role of associate director, basic sciences at the UC Davis Comprehensive Cancer Center and holds the Auburn Community Cancer Endowed Chair in Basic Science.
October 20, 2015
In a study conducted to inform American Cancer Society breast cancer screening guidelines, UC Davis researcher Diana L. Miglioretti reports a screening mammogram once every two years is safe for postmenopausal women at average risk of breast cancer.
October 6, 2015
A UC Davis research team has been awarded $15.5 million to build the world’s first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation’s leading edge of molecular imaging.
September 29, 2015
In an editorial published in the New England Journal of Medicine, Primo Lara, associate director for Translational Research at the UC Davis Comprehensive Cancer Center and David Quinn, medical director, USC Norris Cancer Hospital, highlight two new drugs that have shown great efficacy against kidney cancer.
September 28, 2015
A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues Joshua Fenton, a family physician and comparative effectiveness researcher in an editorial published online today in the Journal of the American Medical Association Internal Medicine.
September 21, 2015
Researchers at UC Davis have shown that the protein LRIG1 reduces breast cancer invasion and could potentially help control metastasis. Using aggressive basal-like breast cancer cell lines, the scientists found that restoring LRIG1 expression reduced these cells’ growth and invasiveness.
September 15, 2015
The UC Davis Comprehensive Cancer Center has joined a unique new collaboration to accelerate the development of precision cancer treatment through the collection and sharing of genomics data
September 9, 2015
Children undergoing cancer treatment at UC Davis Comprehensive Cancer Center take center stage in a series of specially created videos aimed at helping families cope with a new diagnosis, through their treatment journey and into survivorship.
August 18, 2015
In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can “paralyze” CD4 T cells, immune components that help orchestrate the body’s response to pathogens and other invaders.
August 17, 2015
UC Davis clinicians are hoping to greatly advance cancer screenings with the innate olfactory skills of man’s best friend.
August 13, 2015
Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer.
August 11, 2015
mIn findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research from UC Davis has shown.
August 7, 2015
In a check presentation Aug. 6 at the UC Davis Medical Center, Roy Chavez, a UC Davis brain cancer patient and Mule Creek State Prison correctional officer, made a generous gift to support programs and services for children staying at UC Davis Children’s Hospital.
August 6, 2015
Simon Cherry, distinguished professor in the departments of Biomedical Engineering and Radiology, and co-leader of the UC Davis Comprehensive Cancer Center’s Biomedical Technology Program, has been selected to receive a prestigious Outstanding Investigator Award from the National Cancer Institute (NCI).
August 5, 2015
Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis.
July 23, 2015
The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved funding a UC Davis Health System research team to conduct a clinical trial using bioengineered stem cells to treat HIV patients suffering from lymphoma, one of the deadly conditions associated with the disease.
July 21, 2015
UC Davis medical Center has again ranked as one of the best hospitals in the U.S. for 2015-16 in 10 adult medical specialties by U.S. News & World Report.
July 10, 2015
Two faculty members of the UC Davis Department of Radiation Oncology have been recognized for their leadership and expertise in cancer research and care.
July 6, 2015
Scientists at the University of California, Davis, have identified a key mechanism in neuropathic pain. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple sclerosis or other conditions that cause nerve damage.
June 25, 2015
UC Davis stem cell scientist Paul Knoepfler has been awarded $250,000 for glioma research from an organization begun 15 years ago by a 5-year-old girl with a deadly form of childhood cancer.
June 15, 2015
Gary Leiserowitz, chief of gynecologic oncology and interim chair of the Department of Obstetrics and Gynecology, received the Western Association of Gynecologic Oncologists (WAGO) James F. Nolan Award June 12 at the 2015 Annual Meeting in Santa Rosa.
June 15, 2015
Marcio H. Malogolowkin, an international leader in the treatment of rare pediatric liver tumors, has joined UC Davis as the new chief of the UC Davis Division of Pediatric Hematology and Oncology.
May 14, 2015
An international team of scientists, led by UC Davis nephrologist Robert Weiss, have used a sophisticated combination of proteomics and metabolomics to show how renal cell carcinoma (RCC) reprograms its metabolism and evades the immune system. In addition, the study found that cancer grade has a major impact on this reprogramming. These results, published in the journal Cancer Research, point to new therapeutic options for this particularly deadly cancer.
May 1, 2015
The number of surgeries performed on terminally ill cancer patients has not dropped in recent years , despite more attention to the importance of less invasive care for these patients to relieve symptoms and improve quality of life. But new research from UC Davis also finds that the morbidity and mortality among patients with terminal cancer has declined because surgeons are selecting to operate on healthier patients.
April 29, 2015
John M. Boone, a UC Davis medical physicist and professor of radiology, has been awarded a $2.88 million grant from the National Cancer Institute to further develop and research computed tomography (CT) to detect breast cancer.
April 20, 2015
The UC Davis Comprehensive Cancer Center and the Department of Pathology and Laboratory Medicine have entered into a collaboration with Foundation Medicine, a leading molecular information company. The collaboration brings comprehensive genomic profiling into standard of care at UC Davis, allowing physicians to prescribe the most effective, targeted cancer treatments to patients based on the genomic information specific to each individual’s cancer.
April 15, 2015
Two UC Davis researchers will help run a major national study to improve surveillance practices for patients with small lung nodules identified on CT imaging and extremely low risk for lung cancer.
April 7, 2015
The Conquer Cancer Foundation has selected UC Davis medical student Angel Morán for the 2015 American Society of Clinical Oncology (ASCO) Medical Student Rotation for Underrepresented Populations.
April 2, 2015
The micro RNA miR-22 has long been known for its ability to suppress cancer. However, questions remain about how it achieves this feat. For example, which molecules are regulating miR-22, and which are miR22 targets?
March 31, 2015
Researchers at UC Davis have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPARα, which activates liver regeneration. Normally, mouse PPARα is far more active and efficient than the human form, allowing mice to quickly regenerate damaged livers. However, the research shows that protein fibroblast growth factor 21 (FGF21) can boost the regenerative effects of human PPARα.
March 3, 2015
Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells – responsible for a usually fatal type of brain cancer – and could be applicable to other highly aggressive cancers.
February 11, 2015
UC Davis Health System has been endorsed by the American College of Radiology as a designated lung cancer screening center, the only of its kind currently in the greater Sacramento area.
January 28, 2015
Ten months after California legislators enacted a controversial law mandating that radiologists notify women if they have dense breast tissue, UC Davis researchers have found that half of primary care physicians are still unfamiliar with the law and many don’t feel comfortable answering breast density-related questions from patients.
January 21, 2015
UC Davis professor Moon Chen’s research on the under-representation of minorities in clinical trials appears in the American Society in Clinical Oncology (ASCO)’s annual cancer progress report released Tuesday.
December 15, 2014
Scientists have long known the p53 protein suppresses tumors. However, a recent animal study by UC Davis researchers has uncovered a complicated relationship between p53 and another protein, Rbm38, highlighting how the body calibrates protein levels. Too much Rbm38 reduces p53 levels, increasing the risk of cancer. Too little Rbm38 allows p53 overexpression, causing premature aging. The study was published in the journal PNAS on Dec. 15.